Allworth Financial LP boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 3,679.4% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,617 shares of the company's stock after acquiring an additional 8,389 shares during the quarter. Allworth Financial LP's holdings in Bath & Body Works were worth $256,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. Golden State Wealth Management LLC increased its position in Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after buying an additional 642 shares in the last quarter. UMB Bank n.a. increased its position in Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after buying an additional 596 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in Bath & Body Works by 109.7% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company's stock valued at $63,000 after buying an additional 852 shares in the last quarter. Ancora Advisors LLC acquired a new position in Bath & Body Works during the 4th quarter valued at about $67,000. Finally, TD Private Client Wealth LLC increased its position in Bath & Body Works by 34.9% during the 4th quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock valued at $89,000 after buying an additional 593 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.
Bath & Body Works Price Performance
Shares of NYSE:BBWI traded up $1.05 during midday trading on Thursday, hitting $31.83. The company had a trading volume of 1,849,077 shares, compared to its average volume of 5,241,577. The stock has a market cap of $6.74 billion, a price-to-earnings ratio of 8.47, a price-to-earnings-growth ratio of 1.05 and a beta of 1.72. The business's 50-day simple moving average is $30.15 and its 200-day simple moving average is $32.40. Bath & Body Works, Inc. has a twelve month low of $24.94 and a twelve month high of $41.87.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The business had revenue of $1.40 billion for the quarter, compared to analysts' expectations of $1.42 billion. During the same quarter in the previous year, the firm earned $0.38 earnings per share. The business's revenue was up 2.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.51%. The ex-dividend date was Friday, June 6th. Bath & Body Works's dividend payout ratio (DPR) is presently 21.33%.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the company. Raymond James Financial reduced their target price on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research report on Thursday, April 17th. Citigroup increased their price objective on Bath & Body Works from $36.00 to $42.00 and gave the company a "buy" rating in a report on Tuesday, May 20th. The Goldman Sachs Group cut their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a report on Friday, May 30th. Morgan Stanley lowered their target price on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 6th. Finally, Piper Sandler set a $39.00 target price on Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. Four investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, Bath & Body Works currently has an average rating of "Moderate Buy" and a consensus target price of $42.00.
View Our Latest Research Report on BBWI
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
